Table 1. Viral prevalence determined by qPCR in the different sample sites in 121 patients with chronic adenotonsillar disease.
| VIRUS | Any Site*N (%) | Adenoids**N (%) | Palatine TonsilsN (%) | NSN (%) | Peripheral BloodN (%) |
| All Viruses# | 118 (97.5) | 102 (85.7) | 83 (68.6) | 95 (78.5) | 2 (1.6) |
| HAdV | 57 (47.1) | 51 (42.8) | 29 (23.9) | 36 (29.8) | 0 (0.0) |
| HBoV | 36 (29.7) | 28 (23.5) | 6 (4.9) | 14 (11.6) | 2 (1.6) |
| HRV | 46 (38.0) | 30 (25.2) | 15 (12.4) | 42 (34.7) | 0 (0.0) |
| HEV | 49 (40.5) | 37 (31.1) | 45 (37.2) | 22 (18.2) | 0 (0.0) |
| HRSV | 19 (15.7) | 14 (11.8) | 3 (2.5) | 12 (9.9) | 0 (0.0) |
| HMPV | 21 (17.3) | 10 (8.4) | 13 (10.7) | 9 (7.4) | 0 (0.0) |
| FLU | 7 (5.8) | 3 (2.5) | 1 (0.8) | 5 (4.1) | 0 (0.0) |
| HPIV | 6 (4.9) | 4 (3.7) | 3 (2.5) | 1 (0.8) | 0 (0.0) |
| HCoV | 4 (3.3) | 4 (3.7) | 0 (0.0) | 4 (3.3) | 0 (0.0) |
*
Any site: results of viral detection at any of the sites analyzed.
*
Adenoids were obtained only from 119 of the total of 121 patients included in this study.
#
All viruses: positivity for at least one virus by qPCR.